Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Total 13F shares
-
31,217,200
-
Share change
-
+31,217,200
-
Total reported value
-
$676,785,000
-
Price per share
-
$21.68
-
Number of holders
-
43
-
Value change
-
+$676,784,524
-
Number of buys
-
43
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q3 2019
As of 30 Sep 2019,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,217,200 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, BVF INC/IL, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Samsara BioCapital, LLC, and ArrowMark Colorado Holdings LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.